Optic Nerve Sheath Diameter in Pre-Eclamptic Parturient Receiving

Status Recruiting

Clinical Trial Summary

Dexmedetomidine was reported to effectively reduce cerebral metabolism and ICP by decreasing cerebrospinal fluid pressure in patients with cerebral tumors or head injuries that require craniotomy. However, it was also reported to exhibit no effect on ICP. the effect of MgSO4 associated with dexmedetomidine on ONSD in severely pre-eclamptic parturient has been understudied . Though this study aims to evaluate the effect of dexmedetomidine infusion on raised ICP in severely pre-eclamptic parturients using ocular ultrasonography to determine ONSD as a measure of ICP.

Clinical Trial Description

Dexmedetomidine, a highly selective α-2-receptor agonist, is a first-line sedative medication in ICU and has been increasingly used for obstetric anesthesia. Dexmedetomidine, which provides light sedation, possesses analgesic, sympatholytic, anxiolytic properties and attenuates the stress response without significant respiratory depression. In addition, dexmedetomidine-induced stimulation of postsynaptic alpha-2 adrenergic receptor on the cerebral blood vessels can cause cerebral vasoconstriction and decrease cerebral blood flow. However, the effects of dexmedetomidine on ICP are controversial. Clinical signs of raised ICP are not specific and often difficult to interpret, especially during pregnancy and pre-eclampsia. Though the use of invasive devices is considered a gold standard in the measurement of ICP, Ocular sonography is a promising bedside tool, which serves as a noninvasive, readily available, and cost-effective means for indirectly measuring ICP. Bedside ultrasound can be used as a point-of-care tool for rapidly measuring the optic nerve sheath diameter (ONSD), which is a validated indirect means for measuring ICP. An increase in ICP reflects as a raised ONSD since the optic nerve is surrounded by Dural sheath and cerebrospinal fluid (CSF) containing subarachnoid space, which is distensible in the retrobulbar segment, particularly when CSF pressures rise. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05610774
Study type	Interventional
Source	Benha University
Contact	Samar R Amin, MD
Phone	01287793991
Email	samar.rafik@gmail.com
Status	Recruiting
Phase	N/A
Start date	December 20, 2022
Completion date	July 25, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06367868` - Optic Nerve Sheath Diameter: A Non-Invasive Indicator of Intracranial Pressure in the Intensive Care Unit Monitoring	N/A
Recruiting	`NCT02697825` - Intraocular Pressure Versus Optic Nerve Sheath Diameter	N/A
Not yet recruiting	`NCT05485363` - Non-invasive Assessment of Intracranial Pressure Using Ocular Sonography in Patients Undergoing Laparoscopic Sleeve Gastrectomy	N/A
Not yet recruiting	`NCT04092036` - Optic Nerve Sheath Diameter in Prediction of Fluid Responsiveness
Not yet recruiting	`NCT03691025` - Association of the Optic Nerve Sheath Diameter With Eyeball Transverse Diameter in Robot-assisted Prostatectomy
Completed	`NCT03362255` - Measurement of Optic Nerve Sheath Diameter	N/A
Completed	`NCT04412109` - Optic Nerve Sheath Diameter Difference Between Different Injection Volume	N/A
Completed	`NCT04826042` - Effect of Contrast Medium on Optic Nerve Sheath Diameter	N/A
Completed	`NCT03152981` - Analysis of Change of Optic Nerve Sheath Diameter in Robot Assisted Laparoscopic Radical Prostatectomy	N/A
Completed	`NCT03131245` - Optic Nerve Sheath Diameter in Craniosynostosis
Recruiting	`NCT04910087` - The Effect of Anesthesia Management on Optic Nerve Sheath Diameter in the Ercp Procedures	N/A
Recruiting	`NCT04507620` - Effect of Cervical Immobilization on Optic Nerve Sheath Diameter
Recruiting	`NCT06187714` - Effect of Caudal Block Injection Rate on Optic Nerve Sheath Diameter in Pediatric Surgeries
Completed	`NCT04955925` - Effect of Sevoflurane and Propofol on the Optic Nerve Sheath Diameter
Not yet recruiting	`NCT04427085` - Changes of Optic Nerve Sheath Diameter Between Obese and Non-obese Patients Undergoing Laparoscopic Gynecological Surgery	N/A
Completed	`NCT04765397` - Different Resectoscopes Effects to Optic Nerve Sheath Diameter	N/A
Completed	`NCT05499754` - Effect of Different Supralottic Airway Devicess on Optic Nerve Sheath Diameter
Recruiting	`NCT06254534` - Lidocaine, Dexmedetomidine, Esmolol and Magnesium Effect on Optic Nerve Sheath Diameter After Laryngoscopy	N/A
Completed	`NCT05690087` - Lidocaine Infusion on Optic Nerve Sheath Diameter in Laparoscopic Hysterectomy in Trendelenburg Position	N/A
Completed	`NCT03634176` - Optic Nerve Sheath Diameter in Retrobulbar Ultrasound as a Surrogate Measure for Intracranial Pressure Before and After Non-invasive Strategies

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Optic Nerve Sheath Diameter in Pre-Eclamptic Parturient Receiving Magnesium Sulfate Combined With Dexmedetomidine

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms